Search clinical trials for: phase 2a

Total 19259 results

MedImmune LLC

Completed

A Phase 2a to Evaluate the Safety of MEDI8852 in Adults With Uncomplicated Influenza (MEDI8852)

Influenza

United States, South Africa
AbbVie (prior sponsor, Abbott)
Genentech, Inc.

Completed

A Phase 1/2a Study of ABT-263 in Subjects With Small Cell Lung Cancer (SCLC) or Other Non-Hematological Malignancies

Small Cell Lung Carcinoma | Small Cell Lung Cancer

United States, Canada, United Kingdom
University Hospital, Clermont-Ferrand
Ministry of Health, France

Completed

Study of the Type of Pushing at Delivery (EOLE)

Delivery | 2nd Stage of Labor

France
Institut Pasteur

Completed

SF2a-TT15 Conjugate Vaccine in Healthy Adult Volunteers

Shigellosis | Bacillary Dysentery

Israel
MedImmune LLC
Amgen

Completed

Phase 2a Study to Evaluate the Efficacy and Safety of MEDI9929 in Adults With Atopic Dermatitis (ALLEVIAD)

Atopic Dermatitis

United States, Germany, New Zealand, Hungary, Australia, Canada
Ardea Biosciences, Inc.

Completed

Phase 2a RDEA3170 and Allopurinol Combination Study in Gout Subjects

Gout

United States
Biogen

Completed

A Phase 2a Study of BIIB074 in the Treatment of Erythromelalgia

Primary Inherited Erythromelalgia

United States
Alios Biopharma Inc.
Vertex Pharmaceuticals Incorporated

Completed

A Phase 2a, Dose-Ranging Study to Evaluate the Safety, Pharmacokinetics and Efficacy of VX-135 With Ribavirin in Treatment-Naïve Subjects With Chronic Hepatitis C

Chronic Hepatitis C

Moldova, Republic of
Oswaldo Cruz Foundation
IDRI; Biomedical Research Center EPLS; Orygen Biotecnologia SA

Completed

Study of Safety and Immune Response of the Sm14 Vaccine in Adults of Endemic Regions

Schistosomiasis

Senegal
Alios Biopharma Inc.

Completed

A Phase 2a Study to Evaluate Orally Administered ALS-008176 in Adults Hospitalized With a Respiratory Syncytial Virus

Respiratory Syncytial Virus Infections

Australia, Singapore, United States, New Zealand, Taiwan
Strategic Science & Technologies, LLC

Completed

Phase 2a Topical Sildenafil Proof-of-Concept Study in Men With Mild to Moderate ED

Erectile Dysfunction

United States
Endo Pharmaceuticals

Completed

Phase 2a Dose-Ranging Study to Evaluate Safety and Effectiveness of AA4500 in Treatment of Dupuytren's Disease Nodules

Dupuytren's Disease

United States, Australia
Deltanoid Pharmaceuticals

Completed

A Phase 2A Dose-ranging and Pharmacokinetic Study of an Oral Vitamin D Compound (DP001) in Secondary Hyperparathyroidism

Secondary Hyperparathyroidism

United States
AbbVie

Completed

A Phase 2a Study Evaluating the Safety and Efficacy of ABT-981 in Patients With Erosive Hand Osteoarthritis

Erosive Hand Osteoarthritis
Topivert Pharma Ltd

Completed

Phase 2a Study to Evaluate the Safety/Tolerability and Efficacy of TOP1288 200 mg Rectal Solution Once Daily for 4 Weeks in Ulcerative Colitis (TOP2)

Ulcerative Colitis

Poland, Ukraine, United Kingdom, Bulgaria, Hungary, Lithuania, Czechia, Latvia
Oramed, Ltd.
Integrium

Completed

A Prospective, Randomized, Double-blind, Placebo Controlled Study to Assess the Impact of ORMD-0801 (Insulin Capsules) on the Exogenous Insulin Requirements of Type 1 Diabetics

Diabetes Mellitus Type 1

United States
TCM Biotech International Corp.

Withdrawn

The Effects of Adding TCM-700C on the Standard Combination Treatment for HCV Genotype 1 Patients(Phase III)

Chronic Hepatitis C

Taiwan, China
Joel Neal

Terminated

Phase 2a Desipramine in Small Cell Lung Cancer and Other High-Grade Neuroendocrine Tumors

Neuroendocrine Tumors | Small Cell Lung Cancer (SCLC)

United States
Merck Sharp & Dohme LLC

Completed

Peginterferon Dose Evaluations for Previously Untreated Subjects With Chronic Hepatitis C Infected With Genotype 1 (Study P03471)

Hepatitis C, Chronic
Takeda

Terminated

A Phase 2a Pharmacodynamic Study of TAK-448 in Participants With Hypogonadotropic Hypogonadism

Hypogonadotropic Hypogonadism

United Kingdom
Optimer Pharmaceuticals LLC

Completed

OPT-80 in Clostridium Difficile-Associated Diarrhea (CDAD)

Diarrhea

United States
Chong Kun Dang Pharmaceutical
Asan Medical Center

Unknown

A Phase 1/2a Study to Assess the Safety and Efficacy of CKD-516 Tab. in Combination With Irinotecan Inj.

Colorectal Cancer

Korea, Republic of
Stanford University

Terminated

Phase 2 Study of Lovastatin as Breast Cancer Chemoprevention

Breast Cancer

United States
New York State Psychiatric Institute

Completed

Pilot Study of Vyvanse™ In ADHD Adolescents at Risk for Substance Abuse

Attention Deficit Hyperactivity Disorder
Eyegate Pharmaceuticals, Inc.

Completed

OPEN-LABEL, MULTI-CENTER, PHASE 1b/2a CLINICAL TRIAL DESIGNED TO EVALUATE THE SAFETY AND EFFICACY OF IONTOPHORETIC DEXAMETHASONE PHOSPHATE OPHTHALMIC SOLUTION IN PATIENTS HAVING UNDERGONE CATARACT SURGERY WITH IMPLANTATION OF A POSTERIOR CHAMBER INTRAOCULAR LENS (IOL)

Patients Having Undergone Unilateral Cataract Extraction and Implantation of a Monofocal

United States
Hoffmann-La Roche

Completed

HELPS Study - A Study of Peginterferon Alfa-2a (Pegasys) in Patients With Chronic Hepatitis C (CHC) and End-Stage Renal Disease (ESRD)

Hepatitis C, Chronic

France, Greece, Austria, Turkey, United Arab Emirates, Brazil, Italy, Indonesia
Yuhan Corporation

Completed

Phase 1/2a Trial of YH12852 in Healthy Subjects and Patients With Functional Constipation

Functional Constipation

Korea, Republic of
Daewon Pharmaceutical Co., Ltd.

Unknown

Phase 2a Study to Evaluate Optimum Dosage and Stability of DW-3101 in Gastric Inflammation Patients

Acute and Chronic Gastric Inflammation Patients
OncoPep, Inc.

Completed

Phase 1/2a Study of Cancer Vaccine to Treat Smoldering Multiple Myeloma

Smoldering Multiple Myeloma

United States
University of South Florida
Edison Pharmaceuticals Inc

Completed

A Phase 2A Trial of EPI-743 for Patients With Parkinson's Disease

Parkinson's Disease

United States
Eyegate Pharmaceuticals, Inc.

Terminated

Open-label, Multli-center, Phase 1b/2a Clinical Trial Designed to Evaluate the Safety and Efficacy of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution in Patients With Macular Edema

Macular Edema

United States
Pharnext SA
Ascopharm Groupe Novasco

Completed

Pilot Study Assessing the Effects of PXT00864 in Patients With Mild Alzheimer Disease (AD) (PLEODIAL-I)

Alzheimer Disease

France
Pharnext SA
Ascopharm Groupe Novasco

Completed

24-week Open-label Extension Study Evaluating PXT00864 Effect in Mild AD Patients Further to PLEODIAL-I Completion (PLEODIAL-II)

Alzheimer Disease

France
Nantes University Hospital
Medsenic Company

Terminated

Phase 2a Study Evaluating the Arsenic Trioxide (ATO) in Systemic Lupus (SLE) (Protocol LUPSENIC) (LUPSENIC)

Systemic Lupus

France
Bristol-Myers Squibb

Terminated

Chronically-infected HCV Genotype 2 and 3 Treatment-naive Subjects: Part A: Safety and Efficacy of INX-08189 With Peg IFN Alfa-2a and Ribavirin. Part B: INX-08189 in Interferon Free Treatment With Daclatasvir and/or Ribavirin

Hepatitis C

United States
Merck Sharp & Dohme LLC

Completed

A Study to Assess the Effect of Single and Multiple Doses Org 50081 and a Single Dose of Zopiclone on Next-day Driving Ability and Psychomotor Performance in Healthy Volunteers. (P05794) (COMPLETED)

Mental Disorders | Sleep Initiation and Maintenance Disorders
Bristol-Myers Squibb

Completed

Phase III BMS-790052 Add-On to Peg-Interferon Alfa-2a and Ribavirin in Naive Hepatitis C

Hepatitis C

France, United Kingdom, Spain, United States, Italy, Puerto Rico, Greece
Bristol-Myers Squibb

Completed

Phase III Hallmark DUAL: ASV+DCV (Nulls/Partials, Intolerants/Ineligibles. Naives) (Hallmark DUAL)

Hepatitis C Virus

France, Germany, Korea, Republic of, Spain, Taiwan, United States, Canada, Australia, Russian Federation, Austria, Israel, Italy, Netherlands, Argentina, Poland, United Kingdom, Ireland, New Zealand
Bristol-Myers Squibb

Completed

Phase III Hallmark QUAD: ASV+DCV+Peg+Rib (Nulls/Partials) (Hallmark QUAD)

Hepatitis C Virus

United States, Germany, Italy, Korea, Republic of, Sweden, Russian Federation, Canada, France, Argentina, Switzerland, Denmark, Taiwan, Netherlands, Spain, Mexico
Columbia University
Merck Sharp & Dohme LLC

Withdrawn

Boceprevir in End Stage Renal Disease (ESRD)

End Stage Renal Disease | Hepatitis C Infection
LondonPharma Ltd.

Unknown

A Phase 1/2a Study of LON002 in Subjects With Advanced Solid Tumours (LON002-002)

Solid Tumours

United Kingdom
La Jolla Pharmaceutical Company

Completed

A Phase 2a Study of Weekly Doses of GCS-100 in Patients With Chronic Kidney Disease

Chronic Kidney Disease

United States
Southern Illinois University

Withdrawn

Botulinum Toxin Type A for Neuroma Pain

Neuroma

United States
FerruMax Pharmaceuticals, Inc.
Davita Clinical Research

Terminated

A Phase 2A Trial of FMX-8 Treatment for Anemia in Patients With ESRD on Hemodialysis HD

Anemia of Chronic Disease

United States
National Center for Complementary and Integrative...

Completed

Cranberry Juice for Treatment of Urinary Tract Infections

Urinary Tract Infections

United States
Alios Biopharma Inc.

Completed

A Phase 2a Study to Evaluate ALS-008176 in the Virus Challenge Model

Respiratory Syncytial Virus Infections

United Kingdom
Pfizer

Completed

Pharmacokinetics/Pharmacodynamics Biomarker Study in Active Ulcerative Colitis Patients

Colitis, Ulcerative

Canada, United States, France, Netherlands, Germany, Spain, Austria, Hungary, Bulgaria, Poland, Romania
Beijing Bio-Fortune Ltd.

Completed

Recombinant Human Serum Albumin/Interferon alpha2a Fusion Protein Phase Ib Study in Chronic Hepatitis B Patients

Chronic Hepatitis B

China
S1 Biopharma, Inc.

Completed

Phase 1b/2a Unblinded Study of Responses in Premenopausal Women With HSDD to Lorexys Evaluating Efficacy and Safety (PURPLE)

Hypoactive Sexual Desire Disorder (DSM-IV-TR Defined) | Sexual Interest/Arousal Disorder (DSM-5 Defined)

United States
Beijing Kawin Technology Share-Holding Co., Ltd.

Completed

A Phase Ⅱ Dose-escalating Study of PEG-IFN-SA and Ribavirin in IFN Naive Patients With Chronic Hepatitis C

Chronic Hepatitis C

China

3

Subscribe